The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rea, D.
Right arrow Articles by Offringa, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rea, D.
Right arrow Articles by Offringa, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2001, 166: 5236-5244.
Copyright © 2001 by The American Association of Immunologists

Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells1

Delphine Rea2,*, Menzo J. E. Havenga{ddagger}, Maayke van den Assem*, Roger P. M. Sutmuller*, Angelique Lemckert{ddagger}, Rob C. Hoeben{dagger}, Abraham Bout{ddagger}, Cornelis J. M. Melief* and Rienk Offringa3,*

* Department of Immunohematology and Blood Bank and {dagger} Department of Cell Biology, Leiden University Medical Center, Leiden, The Netherlands; and {ddagger} Crucell, Leiden, The Netherlands

The efficiency of dendritic cells (DC) as immunotherapeutic vaccines critically depends on optimal delivery of target Ags. Although DC modified by subgroup C type 5 recombinant adenoviruses (rAd5) provide encouraging results, their clinical application is hampered by the need for high viral titers to achieve sufficient gene transfer, due to the lack of the Ad5 fiber receptor. We now demonstrate that rAd5 carrying subgroup B Ad fibers are up to 100-fold more potent than classical rAd5 for gene transfer and expression in human DC, rAd5 with a type 35 fiber (rAd5F35) being the most efficient vector. This improvement relates to a greater and faster virus entry and to an increased transgene expression especially following DC maturation. Furthermore, these new vectors possess enhanced synergistic effects with other activation signals to trigger DC maturation. Consequently, rAd5F35-infected DC engineered to express the gp100 melanoma-associated Ag largely exceed rAd5-infected DC in activating gp100-specific CTL. Finally, the DC infection pattern of rAd5F35 is fully conserved when DC are in the vicinity of primary skin-derived fibroblasts, suggesting this vector as a candidate for in vivo targeting of DC. Thus, subgroup B fiber-modified rAd5 constitute a major breakthrough in the exploitation of ex vivo rAd-targeted DC as clinically relevant vaccines and may also be suitable for in vivo genetic modification of DC.




This article has been cited by other articles:


Home page
 J. Gen. Virol.Home page
W. C. Adams, E. Bond, M. J. E. Havenga, L. Holterman, J. Goudsmit, G. B. Karlsson Hedestam, R. A. Koup, and K. Lore
Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN
J. Gen. Virol., July 1, 2009; 90(7): 1600 - 1610.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Lore, W. C. Adams, M. Havenga, M. L. Precopio, L. Holterman, J. Goudsmit, and R. A. Koup
Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses
J. Immunol., August 1, 2007; 179(3): 1721 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Tuve, H. Wang, C. Ware, Y. Liu, A. Gaggar, K. Bernt, D. Shayakhmetov, Z. Li, R. Strauss, D. Stone, et al.
A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells
J. Virol., December 15, 2006; 80(24): 12109 - 12120.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. Wang and A. Lieber
A Helper-Dependent Capsid-Modified Adenovirus Vector Expressing Adeno-Associated Virus Rep78 Mediates Site-Specific Integration of a 27-Kilobase Transgene Cassette
J. Virol., December 1, 2006; 80(23): 11699 - 11709.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. D. de Gruijl, O. J. A. E. Ophorst, J. Goudsmit, S. Verhaagh, S. M. Lougheed, K. Radosevic, M. J. E. Havenga, and R. J. Scheper
Intradermal Delivery of Adenoviral Type-35 Vectors Leads to High Efficiency Transduction of Mature, CD8+ T Cell-Stimulating Skin-Emigrated Dendritic Cells
J. Immunol., August 15, 2006; 177(4): 2208 - 2215.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Pichiorri, F. Trapasso, T. Palumbo, R. I. Aqeilan, A. Drusco, B. W. Blaser, D. Iliopoulos, M. A. Caligiuri, K. Huebner, and C. M. Croce
Preclinical Assessment of FHIT Gene Replacement Therapy in Human Leukemia Using a Chimeric Adenovirus, Ad5/F35.
Clin. Cancer Res., June 1, 2006; 12(11): 3494 - 3501.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Lecollinet, F. Gavard, M. J. E. Havenga, O. B. Spiller, A. Lemckert, J. Goudsmit, M. Eloit, and J. Richardson
Improved Gene Delivery to Intestinal Mucosa by Adenoviral Vectors Bearing Subgroup B and D Fibers
J. Virol., March 15, 2006; 80(6): 2747 - 2759.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
S. Verhaagh, E. de Jong, J. Goudsmit, S. Lecollinet, G. Gillissen, M. de Vries, K. van Leuven, I. Que, K. Ouwehand, R. Mintardjo, et al.
Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors
J. Gen. Virol., February 1, 2006; 87(2): 255 - 265.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Knaan-Shanzer, M. J.M. van de Watering, I. van der Velde, M. A.F.V. Goncalves, D. Valerio, and A. A.F. de Vries
Endowing Human Adenovirus Serotype 5 Vectors with Fiber Domains of Species B Greatly Enhances Gene Transfer into Human Mesenchymal Stem Cells
Stem Cells, October 1, 2005; 23(10): 1598 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Fleischli, S. Verhaagh, M. Havenga, D. Sirena, W. Schaffner, R. Cattaneo, U. F. Greber, and S. Hemmi
The Distal Short Consensus Repeats 1 and 2 of the Membrane Cofactor Protein CD46 and Their Distance from the Cell Membrane Determine Productive Entry of Species B Adenovirus Serotype 35
J. Virol., August 1, 2005; 79(15): 10013 - 10022.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Sumida, D. M. Truitt, A. A. C. Lemckert, R. Vogels, J. H. H. V. Custers, M. M. Addo, S. Lockman, T. Peter, F. W. Peyerl, M. G. Kishko, et al.
Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein
J. Immunol., June 1, 2005; 174(11): 7179 - 7185.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Stone, S. Ni, Z.-Y. Li, A. Gaggar, N. DiPaolo, Q. Feng, V. Sandig, and A. Lieber
Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector
J. Virol., April 15, 2005; 79(8): 5090 - 5104.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Krebs, E. Scandella, B. Odermatt, and B. Ludewig
Rapid Functional Exhaustion and Deletion of CTL following Immunization with Recombinant Adenovirus
J. Immunol., April 15, 2005; 174(8): 4559 - 4566.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. H. Barouch, M. G. Pau, J. H. H. V. Custers, W. Koudstaal, S. Kostense, M. J. E. Havenga, D. M. Truitt, S. M. Sumida, M. G. Kishko, J. C. Arthur, et al.
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
J. Immunol., May 15, 2004; 172(10): 6290 - 6297.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Sirena, B. Lilienfeld, M. Eisenhut, S. Kalin, K. Boucke, R. R. Beerli, L. Vogt, C. Ruedl, M. F. Bachmann, U. F. Greber, et al.
The Human Membrane Cofactor CD46 Is a Receptor for Species B Adenovirus Serotype 3
J. Virol., May 1, 2004; 78(9): 4454 - 4462.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
S. Mercier, S. Verhaagh, J. Goudsmit, A. Lemckert, M. Monteil, M. Havenga, and M. Eloit
Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo
J. Gen. Virol., May 1, 2004; 85(5): 1227 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Fontana, M. Nuzzo, L. Urbanelli, and P. Monaci
General Strategy for Broadening Adenovirus Tropism
J. Virol., October 15, 2003; 77(20): 11094 - 11104.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Molinier-Frenkel, A. Prevost-Blondel, S.-S. Hong, R. Lengagne, S. Boudaly, M. K. Magnusson, P. Boulanger, and J.-G. Guillet
The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain
J. Biol. Chem., September 26, 2003; 278(39): 37175 - 37182.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. Thiel, N. Karl, B. Schelle, P. Disterer, I. Klagge, and S. G. Siddell
Multigene RNA Vector Based on Coronavirus Transcription
J. Virol., September 15, 2003; 77(18): 9790 - 9798.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Segerman, J. P. Atkinson, M. Marttila, V. Dennerquist, G. Wadell, and N. Arnberg
Adenovirus Type 11 Uses CD46 as a Cellular Receptor
J. Virol., September 1, 2003; 77(17): 9183 - 9191.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Vogels, D. Zuijdgeest, R. van Rijnsoever, E. Hartkoorn, I. Damen, M.-P. de Bethune, S. Kostense, G. Penders, N. Helmus, W. Koudstaal, et al.
Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity
J. Virol., August 1, 2003; 77(15): 8263 - 8271.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X. Wang, M. Messerle, R. Sapinoro, K. Santos, P. K. Hocknell, X. Jin, and S. Dewhurst
Murine Cytomegalovirus Abortively Infects Human Dendritic Cells, Leading to Expression and Presentation of Virally Vectored Genes
J. Virol., July 1, 2003; 77(13): 7182 - 7192.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Kawakami, H. Li, J. T. Lam, V. Krasnykh, D. T. Curiel, and J. L. Blackwell
Substitution of the Adenovirus Serotype 5 Knob with a Serotype 3 Knob Enhances Multiple Steps in Virus Replication
Cancer Res., March 15, 2003; 63(6): 1262 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Gottschalk, O. L. Edwards, U. Sili, M. H. Huls, T. Goltsova, A. R. Davis, H. E. Heslop, and C. M. Rooney
Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies
Blood, March 1, 2003; 101(5): 1905 - 1912.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. H. Slager, M. Borghi, C. E. van der Minne, C. A. Aarnoudse, M. J. E. Havenga, P. I. Schrier, S. Osanto, and M. Griffioen
CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame
J. Immunol., February 1, 2003; 170(3): 1490 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. W. Schoggins, J. G. D. Gall, and E. Falck-Pedersen
Subgroup B and F Fiber Chimeras Eliminate Normal Adenovirus Type 5 Vector Transduction In Vitro and In Vivo
J. Virol., December 20, 2002; 77(2): 1039 - 1048.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. J. E. Havenga, A. A. C. Lemckert, O. J. A. E. Ophorst, M. van Meijer, W. T. V. Germeraad, J. Grimbergen, M. A. van den Doel, R. Vogels, J. van Deutekom, A. A. M. Janson, et al.
Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease
J. Virol., March 27, 2002; 76(9): 4612 - 4620.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. M. Shayakhmetov, Z.-Y. Li, S. Ni, and A. Lieber
Targeting of Adenovirus Vectors to Tumor Cells Does Not Enable Efficient Transduction of Breast Cancer Metastases
Cancer Res., February 1, 2002; 62(4): 1063 - 1068.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.